Neurobiology of Aging
Volume 29, Issue 7 , Pages 992-1001 , July 2008

Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors

  • Jonathan J. Abbott

      Affiliations

    • King's College London, Wolfson Centre for Age-Related Diseases, Guy's Campus, St Thomas’ Street, London SE1 1UL, UK
    • ,
  • David R. Howlett

      Affiliations

    • Neurology and GI CEDD, GlaxoSmithKline, New Frontiers Science Park, 3rd Avenue, Harlow, Essex CM19 5AW, UK
    • Dr. David Howlett is employed by GlaxoSmithKline R&D.
    • ,
  • Paul T. Francis

      Affiliations

    • King's College London, Wolfson Centre for Age-Related Diseases, Guy's Campus, St Thomas’ Street, London SE1 1UL, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 848 6269; fax: +44 207 848 6240.
    • ,
  • Robert J. Williams

      Affiliations

    • King's College London, Wolfson Centre for Age-Related Diseases, Guy's Campus, St Thomas’ Street, London SE1 1UL, UK

Received 13 November 2006 ,Revised 12 January 2007 ,Accepted 13 January 2007.

References 

  1. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 2001;26(11):657–664
  2. Brown JT, Richardson JC, Collingridge GL, Randall AD, Davies CH. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus. 2005;15(1):110–117
  3. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B, et al. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J. Neurochem. 2003;87(5):1152–1164
  4. Chen QS, Wei WZ, Shimahara T, Xie CW. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 2002;77(3):354–371
  5. Crossthwaite AJ, Hasan S, Williams RJ. Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J. Neurochem. 2002;80(1):24–35
  6. Crossthwaite AJ, Valli H, Williams RJ. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones. J. Neurochem. 2004;88(5):1127–1139
  7. Cullen WK, Wu J, Anwyl R, Rowan MJ. Beta-amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. Neuroreport. 1996;8(1):87–92
  8. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 2001;21(12):4125–4133
  9. Ditaranto K, Tekirian TL, Yang AJ. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 2001;8(1):19–31
  10. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998;273(49):32377–32379
  11. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry. 1999;66(2):137–147
  12. Freir DB, Herron CE. Nicotine enhances the depressive actions of A beta 1–40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J. Neurophysiol. 2003;89(6):2917–2922
  13. Harkany T, Abraham I, Timmerman W, Laskay G, Toth B, Sasvari M, et al. Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur. J. Neurosci. 2000;12(8):2735–2745
  14. Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, et al. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin. FASEB J. 2001;15(1):16–18
  15. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J. Neurosci. 2003;23(26):8967–8977
  16. Jolas T, Zhang XS, Zhang Q, Wong G, Del VR, Gold L, et al. Long-term potentiation is increased in the CA1 area of the hippocampus of APP (swe/ind) CRND8 mice. Neurobiol. Dis. 2002;11(3):394–409
  17. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37(6):925–937
  18. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, et al. Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J. Biol. Chem. 2001;276(17):13541–13546
  19. Kim HS, Park CH, Cha SH, Lee JH, Lee S, Kim Y, et al. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J. 2000;14(11):1508–1517
  20. Klyubin I, Walsh DM, Cullen WK, Fadeeva JV, Anwyl R, Selkoe DJ, et al. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur. J. Neurosci. 2004;19(10):2839–2846
  21. Kubo T, Nishimura S, Oda T. Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Brain Res. Mol. Brain Res. 2002;106(1/2):94–100
  22. Lee DH, Wang HY. Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid 1–40 and beta-amyloid 1–42. J. Neurobiol. 2003;55(1):25–30
  23. Magrane J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW. Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 2005;25(47):10960–10969
  24. Man HY, Wang Q, Lu WY, Ju W, Ahmadian G, Liu L, et al. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron. 2003;38(4):611–624
  25. Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol. Psychiatry. 2003;8(2):217–224
  26. Molnar Z, Soos K, Lengyel I, Penke B, Szegedi V, Budai D. Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. Neuroreport. 2004;15(10):1649–1652
  27. Nomura I, Kato N, Kita T, Takechi H. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci. Lett. 2005;
  28. Opazo P, Watabe AM, Grant SG, O’Dell TJ. Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J. Neurosci. 2003;23(9):3679–3688
  29. Parks JK, Smith TS, Trimmer PA, Bennett JP, Parker WD. Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 2001;76(4):1050–1056
  30. Pei JJ, Khatoon S, An WL, Nordlinder M, Tanaka T, Braak H, et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol. (Berl.). 2003;105(4):381–392
  31. Perkinton MS, Ip JK, Wood GL, Crossthwaite AJ, Williams RJ. Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. J. Neurochem. 2002;80(2):239–254
  32. Perkinton MS, Sihra TS, Williams RJ. Ca(2+)-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons. J. Neurosci. 1999;19(14):5861–5874
  33. Pettit DL, Shao Z, Yakel JL. Beta-amyloid (1–42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 2001;21(1):RC120
  34. Qin Y, Zhu Y, Baumgart JP, Stornetta RL, Seidenman K, Mack V, et al. State-dependent Ras signaling and AMPA receptor trafficking. Genes Dev. 2005;19(17):2000–2015
  35. Richardson JC, Kendal CE, Anderson R, Priest F, Gower E, Soden P, et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience. 2003;122(1):213–228
  36. Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 2004;5(4):317–328
  37. Samanta S, Perkinton MS, Morgan M, Williams RJ. Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J. Neurochem. 1998;70(5):2082–2090
  38. Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, et al. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J. Neurosci. 2002;22(9):3359–3365
  39. Selkoe DJ. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 1994;53(5):438–447
  40. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001;81(2):741–766
  41. Shaw S, Bencherif M, Marrero MB. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1–42) amyloid. J. Biol. Chem. 2002;277(47):44920–44924
  42. Shimohama S, Kihara T. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biol. Psychiatry. 2001;49(3):233–239
  43. Small DH, McLean CA. Alzheimer's disease and the amyloid beta protein: what is the role of amyloid?. J. Neurochem. 1999;73(2):443–449
  44. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005;8(8):1051–1058
  45. Solano DC, Sironi M, Bonfini C, Solerte SB, Govoni S, Racchi M. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J. 2000;14(7):1015–1022
  46. Spencer JP, Weil A, Hill K, Hussain I, Richardson JC, Cusdin FS, et al. Transgenic mice over-expressing human beta-amyloid have functional nicotinic alpha 7 receptors. Neuroscience. 2006;137(3):795–805
  47. Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 2002;22(17):7380–7388
  48. Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB. Beta-amyloid(1–42) binds to alpha7 nicotinic acetylcholine receptor with high affinity, implications for Alzheimer's disease pathology. J. Biol. Chem. 2000;275(8):5626–5632
  49. Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Abeta(1–42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J. Neurochem. 2000;75(3):1155–1161
  50. Wang Q, Rowan MJ, Anwyl R. Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J. Neurosci. 2004;24(27):6049–6056
  51. Ward RV, Jennings KH, Jepras R, Neville W, Owen DE, Hawkins J, et al. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem. J. 2000;348(Pt 1):137–144
  52. Whiteaker P, Davies AR, Marks MJ, Blagbrough IS, Potter BV, Wolstenholme AJ, et al. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur. J. Neurosci. 1999;11(8):2689–2696
  53. Williams RJ, Murphy N, Glowinski J, Premont J. Glucose regulates glutamate-evoked arachidonic acid release from cultured striatal neurons. J. Neurochem. 1995;65(1):241–249
  54. Wu J, Anwyl R, Rowan MJ. Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport. 1995;6(17):2409–2413
  55. Zhao D, Watson JB, Xie CW. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol. 2004;92(5):2853–2858

PII: S0197-4580(07)00013-9

doi: 10.1016/j.neurobiolaging.2007.01.003

Neurobiology of Aging
Volume 29, Issue 7 , Pages 992-1001 , July 2008

Article Tools

* Image Usage & Resolution